z-logo
open-access-imgOpen Access
New FDA ‘Breakthrough’ Designation Aims to Speed Cancer Drug Approvals
Author(s) -
Peggy Eastman
Publication year - 2012
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000425688.25867.04
Subject(s) - drug approval , cancer drugs , drug , medicine , business , pharmacology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here